Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$948K Buy
2,896
+5
+0.2% +$1.59K 0.07% 114
2025
Q3
$816K Sell
2,891
-63
-2% -$18.3K 0.06% 125
2025
Q2
$825K Buy
2,954
+21
+0.7% +$5.95K 0.07% 124
2025
Q1
$914K Buy
2,933
+79
+3% +$23.3K 0.08% 108
2024
Q4
$744K Buy
2,854
+473
+20% +$140K 0.07% 112
2024
Q3
$767K Buy
2,381
+1,353
+132% +$443K 0.07% 101
2024
Q2
$321K Buy
1,028
+5
+0.5% +$1.47K 0.03% 172
2024
Q1
$281K Buy
1,023
+42
+4% +$12.3K 0.03% 186
2023
Q4
$283K Buy
981
+2
+0.2% +$545 0.04% 160
2023
Q3
$263K Hold
979
0.04% 137
2023
Q2
$217K Buy
+979
New +$227K 0.03% 155
2021
Q3
Sell
-891
Closed -$217K 144
2021
Q2
$217K Buy
+891
New +$219K 0.05% 116
2021
Q1
Sell
-881
Closed -$203K 114
2020
Q4
$203K Buy
+881
New +$203K 0.06% 107

Other funds holding AMGN

Austin Private Wealth's AMGN Position: Q4 2025 in Review

Austin Private Wealth increased its Amgen (AMGN) stake by 0.17% in Q4 2025, buying an estimated $1.59K and bringing the position to 2,896 shares worth $948K. The position accounts for 0.07% of the portfolio, ranked #114.

Austin Private Wealth first reported a position in AMGN in Q4 2020 and has held it in 13 quarters since. 3,084 funds tracked by Wall St. Rank hold AMGN as of Q4 2025.

  • Austin Private Wealth held 2,896 shares of Amgen worth $948K as of Q4 2025.
  • Austin Private Wealth bought 5 Amgen shares in Q4 2025, an estimated $1.59K.
  • Amgen made up 0.07% of Austin Private Wealth's portfolio in Q4 2025, its #114 holding.
  • Austin Private Wealth first reported a position in Amgen in Q4 2020 and has held it in 13 quarters since.
  • 3,084 funds tracked by Wall St. Rank held Amgen as of Q4 2025.

Based on Austin Private Wealth's 13F filing for Q4 2025, filed 20 Jan 2026.